Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting

NCT01405248 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT01405248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01405248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting
Lead sponsor
Jinling Hospital, China
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
January 31, 2014
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

restenosis